CapEx at other companies
Other financials
Where this comes from
Reported directly by Corcept Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The official record: Corcept Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corcept Therapeutics's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Corcept Therapeutics's capex?
- Corcept Therapeutics (CORT) reported capex of $201K in Q1 2026.
- How has Corcept Therapeutics's capex changed year-over-year?
- Corcept Therapeutics's capex increased by 93.3% year-over-year, from $104K to $201K.
- What is the long-term trend for Corcept Therapeutics's capex?
- Over 4 years (2021 to 2025), Corcept Therapeutics's capex has grown at a -18.1% compound annual growth rate (CAGR), from $469K to $211K.
- What does capex mean?
- Cash spent on purchasing or maintaining long-term physical assets.
- How do you interpret capex?
- High spending indicates growth investment, while low spending may indicate a focus on cash preservation or asset-light operations.
- How does capex compare across companies?
- Varies significantly by industry; capital-intensive firms have higher CapEx than service-based firms.